Natural cytotoxicity and gnrh agonist administration in advanced endometriosis: positive modulation on natural killer activity

G G Garzetti, G GIOELEGARZETTI, A Ciavattini, Andrea Ciavattini, M Provinciali, Mauro Provinciali, Mario Muzzioli, M Muzzioli, G Di Stefano, Giuseppina Di Stefano, Ν. Fabris, N Fabris
Obstetrics and gynecology · 1996 · vol. 88(2) , pp. 234–240 · doi:10.1016/0029-7844(96)00146-9 · PMID:8692508 · W1989305210
article OA: closed CC0 ⤵ 16 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

GnRH agonist administration for advanced endometriosis increased natural killer cell activity in patients, with higher activity correlating with disease-free follow-up.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To investigate the effects of pharmacologic suppression of ovarian function on the immune system, with respect to the clinical outcome of endometriosis and the possibility of an immunoendocrine combined treatment. METHODS: After informed consent, 25 of 37 patients with revised American Fertility Society stage III and IV endometriosis who underwent postoperative medical treatment were selected and enrolled for this immunoendocrine longitudinal study. Medical treatment consisted of tryptorelinum depot injection, 3.75 mg/month for 24 weeks. Blood samples were collected before the first injection in the early follicular phase, day 2-3 of the cycle, and during medical treatment (every 4 weeks) and follow-up (every 6 months). At the end of the study, we had ten blood samples per patient to evaluate the cytotoxic activity, the number of natural killer cells, and the serum levels of estradiol. Natural killer activity was determined against the K562 cell line by target cell retention of the fluorescent dye carboxyfluorescein diacetate. RESULTS: A positive immunomodulating effect was observed during GnRH agonist administration. In particular, a significant progressive increase in natural killer cell activity was defined within the first 12 weeks of medical treatment; after three injections, we observed the highest values of cytotoxicity, with a median of 7.1 lytic units (range 0.3-14.0; P = .02). Natural cytotoxicity then decreased toward a plateau, which persisted during therapy completation and follow-up, with slight fluctuations. In patients who had recurrence, the values of natural killer cell activity were constantly lower than those in patients with disease-free follow-up, particularly within the first 12 weeks of medical treatment.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Cytotoxicity, Immunologic Endometriosis Killer Cells, Natural Triptorelin Pamoate Adult Cytotoxicity, Immunologic Cytotoxicity, Immunologic Endometriosis Endometriosis Female Follow-Up Studies Humans Killer Cells, Natural Killer Cells, Natural Longitudinal Studies Middle Aged Retrospective Studies Triptorelin Pamoate

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (23)

Cited by (16)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:11:02.671803+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK